REFERENCES
1. Beheshti SO, Madsen CM, Varbo A, Nordestgaard BG. Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects. J Am Coll Cardiol. 2020;75:2553-66.
2. Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013;34:3478-90.
3. Harada-Shiba M, Arai H, Ohmura H, et al. Guidelines for the diagnosis and treatment of adult familial hypercholesterolemia 2022. J Atheroscler Thromb. 2023;30:558-86.
4. Defesche JC, Gidding SS, Harada-Shiba M, Hegele RA, Santos RD, Wierzbicki AS. Familial hypercholesterolaemia. Nat Rev Dis Primers. 2017;3:17093.
5. Hori M, Takahashi A, Son C, Ogura M, Harada-Shiba M. The first Japanese cases of familial hypercholesterolemia due to a known pathogenic APOB gene variant, c.10580 G>A: p.(Arg3527Gln). J Clin Lipidol. 2020;14:482-6.
6. Hutter CM, Austin MA, Humphries SE. Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview. Am J Epidemiol. 2004;160:430-5.
7. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ. 1991;303:893-6.
8. Williams RR, Hunt SC, Schumacher MC, et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol. 1993;72:171-6.
9. Mabuchi H, Ito S, Haba T, Ueda K, Ueda R. Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by Achilles' tendon thickness. Atherosclerosis. 1977;28:61-8.
10. Harada-Shiba M, Arai H, Ishigaki Y, et al. Guidelines for diagnosis and treatment of familial hypercholesterolemia 2017. J Atheroscler Thromb. 2018;25:751-70.
11. Tada H, Hori M, Matsuki K, et al. Achilles tendon thickness assessed by X-ray predicting a pathogenic mutation in familial hypercholesterolemia gene. J Atheroscler Thromb. 2022;29:816-24.
12. Tada H, Kawashiri MA, Nohara A, Inazu A, Mabuchi H, Yamagishi M. Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia. Eur Heart J. 2017;38:1573-9.
13. Michikura M, Hori M, Ogura M, Hosoda K, Harada-Shiba M. The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia. Atherosclerosis. 2022;358:41-6.
14. Michikura M, Ogura M, Hori M, et al. Association of Achilles tendon thickness with lipid profile and carotid IMT in patients with familial hypercholesterolemia. Atherosclerosis. 2025;403:119173.
15. Yamamoto A, Matsuzawa Y, Yokoyama S, Funahashi T, Yamamura T, Kishino B. Effects of probucol on xanthomata regression in familial hypercholesterolemia. Am J Cardiol. 1986;57:29H-35H.
16. Tsouli SG, Xydis V, Argyropoulou MI, Tselepis AD, Elisaf M, Kiortsis DN. Regression of Achilles tendon thickness after statin treatment in patients with familial hypercholesterolemia: an ultrasonographic study. Atherosclerosis. 2009;205:151-5.
17. Bea AM, Perez-Calahorra S, Marco-Benedi V, et al. Effect of intensive LDL cholesterol lowering with PCSK9 monoclonal antibodies on tendon xanthoma regression in familial hypercholesterolemia. Atherosclerosis. 2017;263:92-6.
18. Alam L, Lasam G, Fishberg R. Achilles tendon xanthoma thickness and carotid intima-media thickness in a patient with heterozygous familial hypercholesterolemia on PCSK9 inhibition: a case report and literature review. Cureus. 2020;12:e10497.
19. Munoz-Fernandez AC, Barragan-Carballar C, Villafane JH, et al. A new ultrasound-guided percutaneous electrolysis and exercise treatment in patellar tendinopathy: three case reports. Front Biosci. 2021;26:1166-75.
20. Sánchez Romero EA, Pollet J, Martín Pérez S, et al. Lower limb tendinopathy tissue changes assessed through ultrasound: a narrative review. Medicina. 2020;56:378.
21. Michikura M, Ogura M, Yamamoto M, et al. Achilles tendon ultrasonography for diagnosis of familial hypercholesterolemia among Japanese subjects. Circ J. 2017;81:1879-85.
22. Harada T, Inagaki-Tanimura K, Nagao M, et al. Frequency of achilles tendon Xanthoma in patients with acute coronary syndrome. J Atheroscler Thromb. 2017;24:949-53.
23. Tada H, Kojima N, Takeji Y, Nohara A, Kawashiri MA, Takamura M. Impact of changes in Achilles tendon thickening on cardiovascular events in patients with familial hypercholesterolemia. Am J Prev Cardiol. 2024;18:100660.
24. Descamps OS, Leysen X, Van Leuven F, Heller FR. The use of Achilles tendon ultrasonography for the diagnosis of familial hypercholesterolemia. Atherosclerosis. 2001;157:514-8.
25. Junyent M, Gilabert R, Zambón D, et al. The use of Achilles tendon sonography to distinguish familial hypercholesterolemia from other genetic dyslipidemias. Arterioscler Thromb Vasc Biol. 2005;25:2203-8.
26. Scheel AK, Schettler V, Koziolek M, et al. Impact of chronic LDL-apheresis treatment on Achilles tendon affection in patients with severe familial hypercholesterolemia: a clinical and ultrasonographic 3-year follow-up study. Atherosclerosis. 2004;174:133-9.
27. Sugiyama N, Marcovina S, Gown AM, Seftel H, Joffe B, Chait A. Immunohistochemical distribution of lipoprotein epitopes in xanthomata from patients with familial hypercholesterolemia. Am J Pathol. 1992;141:99-106.
28. Tall AR, Small DM, Lees RS. Interaction of collagen with the lipids of tendon xanthomata. J Clin Invest. 1978;62:836-46.
29. Tsouli SG, Kiortsis DN, Lourida ES, et al. Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemia. J Lipid Res. 2006;47:2208-14.
30. Di Pietro N, Formoso G, Pandolfi A, et al. Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis. Vascul Pharmacol. 2016;84:1-7.
31. Shiels MS, Katki HA, Freedman ND, et al. Cigarette smoking and variations in systemic immune and inflammation markers. J Natl Cancer Inst. 2014;106:dju294.
32. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun. 2010;34:J258-65.
33. Kuschner WG, D'Alessandro A, Wong H, Blanc PD. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J. 1996;9:1989-94.
34. Nakanishi K, Nishida M, Harada M, et al. Klotho-related molecules upregulated by smoking habit in apparently healthy men: a cross-sectional study. Sci Rep. 2015;5:14230.
35. Harats D, Ben-Naim M, Dabach Y, Hollander G, Stein O, Stein Y. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis. 1989;79:245-52.
36. Valkonen M, Kuusi T. Passive smoking induces atherogenic changes in low-density lipoprotein. Circulation. 1998;97:2012-6.
37. Oosterveer DM, Versmissen J, Yazdanpanah M, Defesche JC, Kastelein JJ, Sijbrands EJ. The risk of tendon xanthomas in familial hypercholesterolaemia is influenced by variation in genes of the reverse cholesterol transport pathway and the low-density lipoprotein oxidation pathway. Eur Heart J. 2010;31:1007-12.
38. Artieda M, Cenarro A, Junquera C, et al. Tendon xanthomas in familial hypercholesterolemia are associated with a differential inflammatory response of macrophages to oxidized LDL. FEBS Lett. 2005;579:4503-12.
39. Prosenz J, Rath C, Hadrovic-Avdic M, Hirtler L. The twist of the Achilles tendon - associations of torsions in the lower extremity. Clin Anat. 2018;31:1085-91.
40. Bude RO, Adler RS, Bassett DR. Diagnosis of Achilles tendon xanthoma in patients with heterozygous familial hypercholesterolemia: MR vs sonography. AJR Am J Roentgenol. 1994;162:913-7.
41. Liem MS, Leuven JA, Bloem JL, Schipper J. Magnetic resonance imaging of Achilles tendon xanthomas in familial hypercholesterolemia. Skeletal Radiol. 1992;21:453-7.
42. Koivunen-Niemelä T, Komu M, Viikari J, Alanen A. Magnetic resonance imaging of Achilles tendon xanthomas using a fat-water discrimination technique at 0.1 T. Acad Radiol. 1995;2:319-23.
43. Svendsen K, Olsen T, Vinknes KJ, et al. Risk of stroke in genetically verified familial hypercholesterolemia: a prospective matched cohort study. Atherosclerosis. 2022;358:34-40.
44. Bujo H, Takahashi K, Saito Y, et al. Clinical features of familial hypercholesterolemia in Japan in a database from 1996-1998 by the research committee of the ministry of health, labour and welfare of Japan. J Atheroscler Thromb. 2004;11:146-51.
45. Harada-Shiba M, Ako J, Arai H, et al. Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: results of the EXPLORE-J study. Atherosclerosis. 2018;277:362-8.
46. Akioyamen LE, Tu JV, Genest J, et al. Risk of ischemic stroke and peripheral Arterial disease in heterozygous familial hypercholesterolemia: a meta-analysis. Angiology. 2019;70:726-36.
47. Michikura M, Ogura M, Matsuki K, Yamaoka M, Makino H, Harada-Shiba M. Risk assessment for cardiovascular events using achilles tendon thickness and softness and intima-media thickness in familial hypercholesterolemia. J Atheroscler Thromb. 2024;31:1607-19.
48. Squier K, Scott A, Hunt MA, et al. The effects of cholesterol accumulation on Achilles tendon biomechanics: a cross-sectional study. PLoS One. 2021;16:e0257269.
49. Michikura M, Ogura M, Hori M, Furuta K, Hosoda K, Harada-Shiba M. Achilles tendon softness as a new tool for diagnosing familial hypercholesterolemia. JACC Cardiovasc Imaging. 2021;14:1483-5.
50. Michikura M, Ogura M, Hori M, et al. Association between Achilles tendon softness and atherosclerotic cardiovascular disease in patients with familial hypercholesterolemia. J Atheroscler Thromb. 2022;29:1603-12.
51. Bertolini S, Cantafora A, Averna M, et al. Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype. Arterioscler Thromb Vasc Biol. 2000;20:E41-52.
52. Ogura M, Hori M, Harada-Shiba M. Association between cholesterol efflux capacity and atherosclerotic cardiovascular disease in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2016;36:181-8.
53. Tada H, Okada H, Nohara A, Takamura M, Kawashiri MA. Genetic mutations, regression of Achilles tendon thickness, and cardiovascular events among patients with familial hypercholesterolemia. Atherosclerosis. 2022;340:28-34.
